Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc.

35.20
EUR
+0.80
(+2.33%)
-10.86EPS
Mar 01Next Earn

Important Dates

Acadia Healthcare Company, Inc.'s next confirmed earnings release is scheduled for March 1, 2027.

Earnings Date3/1/2027

Share Statistics

As of September 30, 2026, Acadia Healthcare Company, Inc. has 90.91M shares outstanding.

Shares Outstanding90.91M

Financial Position

As of September 30, 2026, Acadia Healthcare Company, Inc. maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 111.20, indicating elevated leverage, while an interest coverage ratio of -4.79 demonstrates limited ability to service its debt obligations.

Current Ratio1.60
Quick Ratio1.31
Debt / Equity111.20
Debt / EBITDA-3.45
Interest Coverage-4.79

Financial Efficiency

EUR

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a negative return on equity (ROE) of -43.87, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.85, reflecting losses generated across the asset base. The company generates approximately 120,395.45 in revenue per employee across its workforce of 25,000.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 19.52 indicates how many times Acadia Healthcare Company, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-43.87
Return on Assets (ROA)-18.85
Revenue Per Employee120,395.45
Employee Count25,000.00
Inventory Turnover19.52

Taxes

EUR

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. recorded 36.98M in income tax expense. The company reported a pretax loss of -952.85M and -995.23M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax36.98M

Income Statement

EUR

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. generated 3.01B in revenue and converted that into -995.23M in net income, yielding earnings per share of -10.86. EBITDA reached -641.00M, while operating income came in at 294.09M.

Revenue3.01B
Gross Profit2.90B
Operating Income294.09M
Pretax Income-952.85M
Net Income-995.23M
EBITDA-641.00M
EBIT-818.99M
Earnings Per Share (EPS)-10.86

Balance Sheet

EUR

As of September 30, 2026, Acadia Healthcare Company, Inc. holds 144.09M in cash and equivalents against 2.21B in total debt, resulting in a net debt position of 1.93B. Total book value stands at 1.78B, with working capital of 290.53M providing operational flexibility.

Cash & Cash Equivalents144.09M
Total Debt2.21B
Net Debt1.93B
Equity (Book Value)1.78B
Book Value Per Share19.63
Working Capital290.53M

Cash Flow

EUR

Acadia Healthcare Company, Inc. produced 207.51M in operating cash flow over the twelve months ended September 30, 2026.

Operating Cash Flow207.51M
Free Cash Flow207.51M
FCF Per Share2.29

Margins

Over the twelve months ended September 30, 2026, Acadia Healthcare Company, Inc. posted a gross margin of 96.43, reflecting its pricing power and cost economics. The operating margin of 9.77 and net profit margin of -33.07 provide insight into operational efficiency.

Gross Margin96.43
Operating Margin9.77
Pretax Margin-31.66
Profit Margin-33.07
EBITDA Margin-21.30

Stock Splits

Acadia Healthcare Company, Inc.'s most recent stock split took place on November 1, 2011 with a 4:1 split ratio.

Last Split Date11/1/2011
Split Ratio4:1